|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/46 | (2006.01) |
| C12Y 301/27005 | (2013.01) | ||
| C12N 15/113 | (2010.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 38/465 | (2013.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61K 9/0048 | (2013.01) | ||
| A61K 9/0051 | (2013.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Number of the document | 3353304 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16849832.7 |
| Date of filing the European patent application | 2016-09-25 | |
| (97) | Date of publication of the European application | 2018-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2022-10-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/053629 |
| Date | 2016-09-25 |
| (87) | Number | WO 2017/053923 |
| Date | 2017-03-30 |
| (30) | Number | Date | Country code |
| 201562233267 P | 2015-09-25 | US |
| (72) |
STREM, Brian , US
|
| (73) |
Okogen, Inc. ,
332 Encinitas Blvd., Suite 102, Encinitas, CA 92024,
US
|
| (54) | VIRAL CONJUNCTIVITIS TREATMENT USING RANPIRNASE |
| VIRAL CONJUNCTIVITIS TREATMENT USING RANPIRNASE |